321 related articles for article (PubMed ID: 37298344)
1. Impact of Solute Carrier Transporters in Glioma Pathology: A Comprehensive Review.
Anagnostakis F; Kokkorakis M; Markouli M; Piperi C
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298344
[TBL] [Abstract][Full Text] [Related]
2. Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy.
Hushmandi K; Einollahi B; Saadat SH; Lee EHC; Farani MR; Okina E; Huh YS; Nabavi N; Salimimoghadam S; Kumar AP
Mol Metab; 2024 Jun; 84():101952. PubMed ID: 38705513
[TBL] [Abstract][Full Text] [Related]
3. Targeting SLC transporters: small molecules as modulators and therapeutic opportunities.
Schlessinger A; Zatorski N; Hutchinson K; Colas C
Trends Biochem Sci; 2023 Sep; 48(9):801-814. PubMed ID: 37355450
[TBL] [Abstract][Full Text] [Related]
4. Membrane transporters in cell physiology, cancer metabolism and drug response.
Alam S; Doherty E; Ortega-Prieto P; Arizanova J; Fets L
Dis Model Mech; 2023 Nov; 16(11):. PubMed ID: 38037877
[TBL] [Abstract][Full Text] [Related]
5. Role of solute carrier transporters in regulating dendritic cell maturation and function.
Shao L; Yang M; Sun T; Xia H; Du D; Li X; Jie Z
Eur J Immunol; 2024 Feb; 54(2):e2350385. PubMed ID: 38073515
[TBL] [Abstract][Full Text] [Related]
6. Multi-omics analysis reveals the association between specific solute carrier proteins gene expression patterns and the immune suppressive microenvironment in glioma.
Wu W; Jiang C; Zhu W; Jiang X
J Cell Mol Med; 2024 May; 28(9):e18339. PubMed ID: 38687049
[TBL] [Abstract][Full Text] [Related]
7. Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic Disease.
Schumann T; König J; Henke C; Willmes DM; Bornstein SR; Jordan J; Fromm MF; Birkenfeld AL
Pharmacol Rev; 2020 Jan; 72(1):343-379. PubMed ID: 31882442
[TBL] [Abstract][Full Text] [Related]
8. Targeting solute carriers to modulate receptor-ligand interactions.
Sijben HJ; Superti-Furga G; IJzerman AP; Heitman LH
Trends Pharmacol Sci; 2022 May; 43(5):358-361. PubMed ID: 35232590
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a novel microscale thermophoresis ligand-binding assay for characterization of SLC solute carriers using oligopeptide transporter PepT1 (SLC15 family) as a model system.
Clémençon B; Lüscher BP; Hediger MA
J Pharmacol Toxicol Methods; 2018; 92():67-76. PubMed ID: 29580877
[TBL] [Abstract][Full Text] [Related]
10. Rational exploration of fold atlas for human solute carrier proteins.
Xie T; Chi X; Huang B; Ye F; Zhou Q; Huang J
Structure; 2022 Sep; 30(9):1321-1330.e5. PubMed ID: 35700727
[TBL] [Abstract][Full Text] [Related]
11. Potentiating SLC transporter activity: Emerging drug discovery opportunities.
Rives ML; Javitch JA; Wickenden AD
Biochem Pharmacol; 2017 Jul; 135():1-11. PubMed ID: 28214518
[TBL] [Abstract][Full Text] [Related]
12. Exploiting Cysteine Residues of SLC Membrane Transporters as Targets for Drugs.
Scalise M; Console L; Galluccio M; Pochini L; Tonazzi A; Giangregorio N; Indiveri C
SLAS Discov; 2019 Oct; 24(9):867-881. PubMed ID: 31251685
[TBL] [Abstract][Full Text] [Related]
13. Transporter-Mediated Drug Delivery.
Gyimesi G; Hediger MA
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770817
[TBL] [Abstract][Full Text] [Related]
14. Advances and Challenges in Rational Drug Design for SLCs.
Garibsingh RA; Schlessinger A
Trends Pharmacol Sci; 2019 Oct; 40(10):790-800. PubMed ID: 31519459
[TBL] [Abstract][Full Text] [Related]
15. SLC Family Transporters.
Liu X
Adv Exp Med Biol; 2019; 1141():101-202. PubMed ID: 31571165
[TBL] [Abstract][Full Text] [Related]
16. Amino Acids and Their Transporters in T Cell Immunity and Cancer Therapy.
Wang W; Zou W
Mol Cell; 2020 Nov; 80(3):384-395. PubMed ID: 32997964
[TBL] [Abstract][Full Text] [Related]
17. Harnessing Solute Carrier Transporters for Precision Oncology.
Nyquist MD; Prasad B; Mostaghel EA
Molecules; 2017 Mar; 22(4):. PubMed ID: 28350329
[TBL] [Abstract][Full Text] [Related]
18. A guide to plasma membrane solute carrier proteins.
Pizzagalli MD; Bensimon A; Superti-Furga G
FEBS J; 2021 May; 288(9):2784-2835. PubMed ID: 32810346
[TBL] [Abstract][Full Text] [Related]
19. Recent developments in ligands and chemical probes targeting solute carrier transporters.
Casiraghi A; Bensimon A; Superti-Furga G
Curr Opin Chem Biol; 2021 Jun; 62():53-63. PubMed ID: 33689964
[TBL] [Abstract][Full Text] [Related]
20. Niosomes decorated with dual ligands targeting brain endothelial transporters increase cargo penetration across the blood-brain barrier.
Mészáros M; Porkoláb G; Kiss L; Pilbat AM; Kóta Z; Kupihár Z; Kéri A; Galbács G; Siklós L; Tóth A; Fülöp L; Csete M; Sipos Á; Hülper P; Sipos P; Páli T; Rákhely G; Szabó-Révész P; Deli MA; Veszelka S
Eur J Pharm Sci; 2018 Oct; 123():228-240. PubMed ID: 30031862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]